ID

23425

Descripción

Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone; ODM derived from: https://clinicaltrials.gov/show/NCT00402909

Link

https://clinicaltrials.gov/show/NCT00402909

Palabras clave

Versiones (1)
  1. 4/7/17 4/7/17 -
Subido en

4 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 2 Diabetes NCT00402909

Inglés

Eligibility Type 2 Diabetes NCT00402909

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male/female, age 18-78 inclusive
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
type 2 diabetes, taking glargine, metformin and/or thiazolidinedione for 3 months prior to screening, stable doses for 2 months prior to screening
Descripción

Diabetes Mellitus, Non-Insulin-Dependent | Glargine Dose Stable | Metformin Dose Stable | Thiazolidinediones Dose Stable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0907402
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
UMLS CUI [3,1]
C0025598
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
UMLS CUI [4,1]
C1257987
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
hba1c 7.0-8.5% inclusive
Descripción

Glycosylated hemoglobin A

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019018
fasting plasma glucose <240 mg/dl at screening
Descripción

Plasma fasting glucose measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0583513
body mass index 22-41 kg/m2
Descripción

Body mass index

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1305855
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or nursing
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
other investigational drugs within 30 days of screening
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
treatment with other anti-diabetic medications other than metformin, glargine and/or thiazolidinedione
Descripción

Antidiabetics | Metformin | Glargine | Thiazolidinediones

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0935929
UMLS CUI [2]
C0025598
UMLS CUI [3]
C0907402
UMLS CUI [4]
C1257987
history of type 1 diabetes
Descripción

Diabetes Mellitus, Insulin-Dependent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0011854
abnormal kidney function
Descripción

Abnormal renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0151746
history of acute diabetic complications
Descripción

Complications of Diabetes Mellitus

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0342257
congestive heart failure requiring treatment
Descripción

Congestive heart failure Treatment required for

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0332121
myocardial infarction, coronary artery surgery, stroke within 6 months of screening
Descripción

Myocardial Infarction | Coronary Artery Bypass Surgery | Cerebrovascular accident

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0010055
UMLS CUI [3]
C0038454
liver disease, liver enzymes more than 3 times upper limit of normal
Descripción

Liver diseases | Elevated liver enzymes

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0235996
fasting triglycerides >700 mg/dl within past 12 weeks
Descripción

Serum fasting triglyceride measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0582824
acute infections or other conditions that may affect blood sugar or may interfere with interpretation of study data
Descripción

Communicable Diseases Affecting Blood Glucose | Communicable Diseases Interfere with Interpretation research data | Condition Affecting Blood Glucose | Condition Interferes with Interpretation research data

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0005802
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0459471
UMLS CUI [2,4]
C0681873
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C0005802
UMLS CUI [4,1]
C0348080
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0459471
UMLS CUI [4,4]
C0681873
treatment with corticosteroids
Descripción

Adrenal Cortex Hormones

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001617
blood donation within past 12 weeks
Descripción

Blood Donation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005794
other protocol-defined inclusion/exclusion criterial may apply.
Descripción

Clinical Trial Eligibility Criteria Study Protocol

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Volver a la parte superior de la página

Similar models

Eligibility Type 2 Diabetes NCT00402909

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male/female, age 18-78 inclusive
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | Glargine Dose Stable | Metformin Dose Stable | Thiazolidinediones Dose Stable
Item
type 2 diabetes, taking glargine, metformin and/or thiazolidinedione for 3 months prior to screening, stable doses for 2 months prior to screening
boolean
C0011860 (UMLS CUI [1])
C0907402 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0025598 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C1257987 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
Glycosylated hemoglobin A
Item
hba1c 7.0-8.5% inclusive
boolean
C0019018 (UMLS CUI [1])
Plasma fasting glucose measurement
Item
fasting plasma glucose <240 mg/dl at screening
boolean
C0583513 (UMLS CUI [1])
Body mass index
Item
body mass index 22-41 kg/m2
boolean
C1305855 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Investigational New Drugs
Item
other investigational drugs within 30 days of screening
boolean
C0013230 (UMLS CUI [1])
Antidiabetics | Metformin | Glargine | Thiazolidinediones
Item
treatment with other anti-diabetic medications other than metformin, glargine and/or thiazolidinedione
boolean
C0935929 (UMLS CUI [1])
C0025598 (UMLS CUI [2])
C0907402 (UMLS CUI [3])
C1257987 (UMLS CUI [4])
Diabetes Mellitus, Insulin-Dependent
Item
history of type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Abnormal renal function
Item
abnormal kidney function
boolean
C0151746 (UMLS CUI [1])
Complications of Diabetes Mellitus
Item
history of acute diabetic complications
boolean
C0342257 (UMLS CUI [1])
Congestive heart failure Treatment required for
Item
congestive heart failure requiring treatment
boolean
C0018802 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
Myocardial Infarction | Coronary Artery Bypass Surgery | Cerebrovascular accident
Item
myocardial infarction, coronary artery surgery, stroke within 6 months of screening
boolean
C0027051 (UMLS CUI [1])
C0010055 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
Liver diseases | Elevated liver enzymes
Item
liver disease, liver enzymes more than 3 times upper limit of normal
boolean
C0023895 (UMLS CUI [1])
C0235996 (UMLS CUI [2])
Serum fasting triglyceride measurement
Item
fasting triglycerides >700 mg/dl within past 12 weeks
boolean
C0582824 (UMLS CUI [1])
Communicable Diseases Affecting Blood Glucose | Communicable Diseases Interfere with Interpretation research data | Condition Affecting Blood Glucose | Condition Interferes with Interpretation research data
Item
acute infections or other conditions that may affect blood sugar or may interfere with interpretation of study data
boolean
C0009450 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0005802 (UMLS CUI [1,3])
C0009450 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0459471 (UMLS CUI [2,3])
C0681873 (UMLS CUI [2,4])
C0348080 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0005802 (UMLS CUI [3,3])
C0348080 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0459471 (UMLS CUI [4,3])
C0681873 (UMLS CUI [4,4])
Adrenal Cortex Hormones
Item
treatment with corticosteroids
boolean
C0001617 (UMLS CUI [1])
Blood Donation
Item
blood donation within past 12 weeks
boolean
C0005794 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criterial may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial